Question

The nurse is reviewing a medication history of a client with BPH. Which medication should be recognized as likely to aggravate BPH?

1) Metformin (Glucophage)
2) Buspirone (BuSpar)
3) Inhaled ipratropium (Atrovent)
4) Ophthalmic timolol (Timoptic)

Answer 1

The medication that should be recognized as likely to aggravate benign prostatic hypertrophy (BPH) is 3) Inhaled ipratropium (Atrovent). Ipratropium is an anticholinergic medication that can cause urinary retention and worsen symptoms associated with BPH

Answer 2

The medication likely to aggravate BPH is inhaled ipratropium (Atrovent) due to its anticholinergic effects. This contrasts with diuretics, which increase urine frequency by inhibiting sodium and chloride reabsorption in the kidneys, particularly in the loop of Henle.

Step-by-step explanation:

The nurse is reviewing a medication history of a client with Benign Prostatic Hyperplasia (BPH). The medication that should be recognized as likely to aggravate BPH is 3) Inhaled ipratropium (Atrovent). This is because ipratropium is an anticholinergic agent, which can cause urinary retention by inhibiting bladder contraction, thus potentially worsening symptoms in individuals with BPH. The mechanism behind this is related to the blocking of acetylcholine receptors, which play a key role in bladder muscle contractions. Therefore, it is important for a nurse to recognize the potential impact of inhaled ipratropium on a client's BPH condition.

A drug that has a side effect that increases the frequency of urination is typically a diuretic, not an oliguric. Diuretics, such as loop diuretics, work by inhibiting the reabsorption of sodium and chloride in the loop of Henle in the kidneys. This action leads to increased output of urine, as more water is excreted due to the osmotic pull of the unabsorbed ions. Examples of loop diuretics include furosemide and bumetanide, which are often used to treat conditions like hypertension and edema.